BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8427040)

  • 1. Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus.
    Morgeaux S; Tordo N; Gontier C; Perrin P
    Vaccine; 1993; 11(1):82-90. PubMed ID: 8427040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of DNA by beta-propiolactone.
    Perrin P; Morgeaux S
    Biologicals; 1995 Sep; 23(3):207-11. PubMed ID: 8527119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inactivation of the rabies virus by ascorbic acid.
    Madhusudana SN; Shamsundar R; Seetharaman S
    Int J Infect Dis; 2004 Jan; 8(1):21-5. PubMed ID: 14690777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonal-centrifuged human diploid cell rabies vaccine.
    Majer M; Hilfenhaus J; Mauler R; Hennessen W
    Dev Biol Stand; 1976 Dec 13-15; 37():267-71. PubMed ID: 801472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inactivated viral vaccines (human) on frequency of micronuclei in bone marrow erythrocytes of mice.
    Rao LV; Polasa H
    Indian J Exp Biol; 1991 Jul; 29(7):683-5. PubMed ID: 1794857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potency studies of sample rabies vaccine, inactivated by beta-propiolactone].
    Akan E
    Turk Hij Tecr Biyol Derg (1961); 1976; 36(2):172-88. PubMed ID: 1023462
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of human rabies vaccine in VERO cell culture using a microcarrier system.
    Mendonça RZ; Ioshimoto LM; Mendonça RM; De-Franco M; Valentini EJ; Beçak W; Raw I; Pereira CA
    Braz J Med Biol Res; 1993 Dec; 26(12):1305-17. PubMed ID: 8136732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine.
    Jones RL; Froeschle JE; Atmar RL; Matthews JS; Sanders R; Pardalos J; Moeller L; Chin JE; Famula M; Briggs DJ; Lang J
    Vaccine; 2001 Sep; 19(32):4635-43. PubMed ID: 11535311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine.
    Anderson MC; Baer H; Frazier DJ; Quinnan GV
    J Allergy Clin Immunol; 1987 Dec; 80(6):861-8. PubMed ID: 3693763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of rabies virus inactivated by -propiolactone, acetylethyleneimine, and ionizing irradiation.
    Wiktor TJ; Aaslestad HG; Kaplan MM
    Appl Microbiol; 1972 May; 23(5):914-8. PubMed ID: 5031561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores.
    Rupprecht CE; Dietzschold B; Campbell JB; Charlton KM; Koprowski H
    J Wildl Dis; 1992 Oct; 28(4):629-35. PubMed ID: 1474662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids.
    Fan C; Ye X; Ku Z; Kong L; Liu Q; Xu C; Cong Y; Huang Z
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethylenimine-inactivated rabies vaccine of tissue culture origin.
    Larghi OP; Savy VL; Nebel AE; Rodriguez A
    J Clin Microbiol; 1976 Jan; 3(1):26-33. PubMed ID: 1254701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus.
    Wiktor TJ; Doherty PC; Koprowski H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):334-8. PubMed ID: 299948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of rabies virus by hydrogen peroxide.
    Abd-Elghaffar AA; Ali AE; Boseila AA; Amin MA
    Vaccine; 2016 Feb; 34(6):798-802. PubMed ID: 26731189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified rabies vaccine (suckling rat brain origin).
    Lavender JF
    Appl Microbiol; 1970 Jun; 19(6):923-7. PubMed ID: 5456012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Different Stabilizers and Inactivating Compounds for the Enhancement of Vero Cell Rabies Vaccine Stability and Immunogenicity:
    Olayan E; El-Khadragy M; Mohamed AF; Mohamed AK; Shebl RI; Yehia HM
    Biomed Res Int; 2019; 2019():4518163. PubMed ID: 31008105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of beta-propiolactone in duck embryo rabies vaccine.
    Peck FB
    Vox Sang; 1969 Jul; 17(1):62-3. PubMed ID: 5798765
    [No Abstract]   [Full Text] [Related]  

  • 19. Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL).
    CULBERTSON CG; PECK FB; POWELL HM
    J Am Med Assoc; 1956 Dec; 162(15):1373-6. PubMed ID: 13376304
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.
    Sasaki Y; Yoshino N; Sato S; Muraki Y
    J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.